➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Merck
Mallinckrodt
Medtronic
McKinsey

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084428

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 084428 describes PROPANTHELINE BROMIDE, which is a drug marketed by Ascot, Heather, Hikma, Impax Labs, Mylan, Par Pharm, Pvt Form, Sandoz, Tablicaps, and Watson Labs, and is included in eleven NDAs. It is available from one supplier. Additional details are available on the PROPANTHELINE BROMIDE profile page.

The generic ingredient in PROPANTHELINE BROMIDE is propantheline bromide. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the propantheline bromide profile page.
Summary for 084428
Tradename:PROPANTHELINE BROMIDE
Applicant:Tablicaps
Ingredient:propantheline bromide
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084428

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength15MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.